AGILENT TECHNOLOGIES, INC. is 24.8x more valuable than Alamar Biosciences, Inc. by market capitalization ($37.02 B vs $1.49 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALMR | A |
|---|---|---|
| Market cap | $1.49 B | $37.02 B |
| US-listed rank | #2318 | #407 |
| Revenue (latest FY) | - | $6.95B |
| Net income (latest FY) | - | $1.30B |
| Net margin | - | 18.8% |
| P/E (trailing FY) | - | 28.4 |
| SEC filings | 38 | 2,339 |
AGILENT TECHNOLOGIES, INC. is 24.8x more valuable than Alamar Biosciences, Inc. by market capitalization ($37.02 B vs $1.49 B).
Full pages: Alamar Biosciences, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.